You are viewing: Asia Pacific Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Asia Pacific Long Read Sequencing Market was valued at $100.7 Million in 2024 and projected to reach to $450.4 Million by 2029, representing a compound annual growth rate of 34.9%. The Asia Pacific long read sequencing market is positioned for exceptional growth through 2029, driven by increasing investments in genomic research infrastructure, rising prevalence of genetic disorders, and growing adoption of personalized medicine approaches.

Asia Pacific Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific Long Read Sequencing Market Trends and Insights

  • Asia Pacific's growth trajectory reflects increasing adoption of advanced genomic technologies across research institutions, clinical laboratories, and pharmaceutical companies throughout the region.
  • The market's 34.9% compound annual growth rate significantly outpaces global trends, driven by rising investments in precision medicine, genomic research infrastructure, and government initiatives supporting biotechnology development across Asia Pacific nations. Asia Pacific's long read sequencing market benefits from a growing population of genomics researchers, expanding healthcare budgets, and increasing prevalence of genetic disorders requiring advanced diagnostic capabilities.
  • Key markets within Asia Pacific, including China, Japan, South Korea, and India, are establishing themselves as innovation hubs for sequencing technology adoption and development.
  • Between 2024 and 2029, Asia Pacific is expected to capture substantial market share as healthcare systems modernize and research institutions prioritize long read sequencing for complex genomic analysis, structural variant detection, and personalized medicine applications..

Key Market Statistics

  • CAGR (2024-2029) 34.9% CAGR
  • Market Size, 2024 ~USD 100.7 Million
  • Forecast, 2029 ~USD 450.4 Million
  • Geography Asia Pacific

Asia Pacific Long Read Sequencing Market Overview

Rapid Market Expansion :

Asia Pacific's long read sequencing market is valued at $100.7 million in 2024 and is projected to reach $450.4 million by 2029, representing a robust 34.9% CAGR that outpaces the global growth rate of 32.8%.

China's Market Leadership :

China dominates the Asia Pacific region with a market size of $198.2 million, driven by substantial investments in genomic research infrastructure and increasing adoption of advanced sequencing technologies across academic and commercial sectors.

Emerging Research Hub Growth :

Japan ($78.5 million) and India ($59.1 million) are emerging as significant growth centers, with expanding research institutions and clinical laboratories increasingly integrating long read sequencing into their genomic analysis capabilities.

Technology Adoption Acceleration :

Rising demand from pharmaceutical companies, biotechnology firms, and research institutions across Asia Pacific is accelerating the adoption of long read sequencing for complex genomic applications and precision medicine initiatives.

Asia Pacific Long Read Sequencing Market Dynamics

  • Government initiatives supporting biotechnology development and expanding healthcare budgets across major economies are creating favorable conditions for market expansion. Key growth drivers include the establishment of advanced research centers, collaborations between international and regional players, and increasing clinical applications of long read sequencing.
  • The region's young population, coupled with rising healthcare awareness and improving laboratory capabilities, will continue to fuel demand for sophisticated genomic analysis tools and services throughout the forecast period..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Asia Pacific's long read sequencing market is valued at $100.7 million in 2024 and will grow to $450.4 million by 2029, representing a 34.9% CAGR.
    • Asia Pacific demonstrates stronger growth momentum than global markets, driven by increased genomic research funding and precision medicine adoption across the region.
    • Key Asia Pacific markets including China, Japan, South Korea, and India are rapidly expanding sequencing infrastructure and clinical applications.
    • Asia Pacific's market expansion is supported by government biotechnology initiatives, rising healthcare investments, and growing demand for advanced diagnostic capabilities.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Asia Pacific Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Sequencing Technology Providers : Manufacturers and vendors of long read sequencing platforms need Asia Pacific market data to identify regional demand patterns, optimize product positioning, and develop localized commercialization strategies for high-growth markets.
    • Research Institutions & Universities : Academic and research organizations across Asia Pacific require market intelligence to justify genomic technology investments, benchmark capabilities against regional peers, and align research initiatives with market trends.
    • Clinical Laboratory Operators : Diagnostic and clinical laboratories need comprehensive market insights to evaluate long read sequencing adoption opportunities, assess competitive positioning, and plan service expansion across Asia Pacific regions.
    • Pharmaceutical & Biotech Companies : Drug development and biotech firms operating in Asia Pacific require regional market data to support precision medicine initiatives, clinical trial planning, and genomic research investments aligned with market growth.
    • Healthcare Investors & Consultants : Investment firms and management consultants need detailed Asia Pacific market analysis to evaluate portfolio opportunities, assess market attractiveness, and provide strategic guidance to healthcare and life sciences clients.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 779 Million · 33.1% wtd CAGR ·
    Europe
    ~USD 526.3 Million · 33.7% wtd CAGR ·
    Latin America
    ~USD 86.8 Million · 29.9% wtd CAGR ·
    Middle East
    ~USD 73.3 Million · 27.6% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    ChinaUSD 198.2 Million
    JapanUSD 78.5 Million
    IndiaUSD 59.1 Million
    South KoreaUSD 10.3 Million
    Rest Of Asia PacificUSD 104.3 Million

    Country market size visualization

    China
    USD 198.2 Million
    Japan
    USD 78.5 Million
    India
    USD 59.1 Million
    South Korea
    USD 10.3 Million
    Rest Of Asia Pacific
    USD 104.3 Million

    Reasons to Buy this Report

    • Regional Market Insights : Gain comprehensive understanding of Asia Pacific's long read sequencing market dynamics, including country-specific valuations for China ($198.2M), Japan ($78.5M), and India ($59.1M) to identify high-potential investment opportunities.
    • Growth Trajectory Analysis : Access detailed forecasts showing 34.9% CAGR through 2029, enabling strategic planning and resource allocation decisions for market entry or expansion across Asia Pacific's fastest-growing genomic technology segment.
    • Competitive Positioning : Understand regional adoption patterns, technology preferences, and competitive landscapes across major Asia Pacific markets to develop targeted go-to-market strategies and differentiation approaches.
    • Investment Decision Support : Leverage market size projections and growth metrics to support investment decisions, partnership evaluations, and M&A strategies within Asia Pacific's rapidly expanding long read sequencing ecosystem.
    • Emerging Market Opportunities : Identify emerging opportunities in secondary markets like South Korea ($10.3M) and Rest of Asia Pacific ($104.3M) with significant growth potential as genomic adoption accelerates across the region.

    Frequently asked questions

    What is the current market size of long read sequencing in Asia Pacific?

    The Asia Pacific long read sequencing market was valued at $100.7 million in 2024 and is projected to reach $450.4 million by 2029.

    What is the growth rate for long read sequencing in Asia Pacific?

    Asia Pacific's long read sequencing market is growing at a compound annual growth rate (CAGR) of 34.9% from 2024 to 2029.

    Which countries are driving growth in Asia Pacific's long read sequencing market?

    Key markets within Asia Pacific including China, Japan, South Korea, and India are primary drivers of long read sequencing adoption and market expansion.

    What factors are accelerating long read sequencing adoption in Asia Pacific?

    Asia Pacific's market growth is driven by increased genomic research funding, government biotechnology initiatives, expanding healthcare budgets, and rising demand for precision medicine applications.

    How does Asia Pacific's growth compare to the global long read sequencing market?

    Asia Pacific's 34.9% CAGR significantly exceeds the global market CAGR of 32.8%, indicating the region is a key growth engine for long read sequencing technologies.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status